As with other early infections in recent months, including RSV and flu, invasive group A streptococcal cases were reported earlier in the season than is typical
Rates of Macrolide Resistance in S. pneumoniae High Across the U.S.
Clinicians should consider alternatives to macrolide monotherapy as empiric therapy for suspected community-acquired bacterial pneumonia